Pathogenetic justification of sacubitril / valsartan use in respiratory-cardial comorbidity
Among the comorbid conditions that significantly worsen quality of life and life expectancy are the chronic obstructive pulmonary disease and heart failure. Difficulties of drug therapy are the mutually exclusive approaches in the treatment of chronic obstructive pulmonary disease and concomitant ca...
Saved in:
| Main Authors: | T. V. Ashcheulova, K. M. Kompaniiets, N. M. Herasymchuk, I. V. Sytina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2023-01-01
|
| Series: | Patologìâ |
| Subjects: | |
| Online Access: | http://pat.zsmu.edu.ua/article/view/266425/268980 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Supramolecular complex sacubitril/valsartan - the first representative of a new class of drugs for the treatment of chronic heart failure
by: T. V. Ashcheulova, et al.
Published: (2019-12-01) -
BOLD MRI to Evaluate the Effects of Sacubitril/Valsartan on Renal Protection in Type 2 Diabetics
by: Zhai L, et al.
Published: (2025-05-01) -
Effect of sacubitril/valsartan on inflammation and oxidative stress in doxorubicin-induced heart failure model in rabbits
by: Yu Chun, et al.
Published: (2021-09-01) -
EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
by: Zh. D. Kobalava, et al.
Published: (2017-07-01) -
Progress of sacubitril valsartan in researches on chronic kidney disease with diabetes and cardiovascular disease
by: YANG Hui-juan, et al.
Published: (2020-01-01)